-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Soleno Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- Soleno Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$21.9M, a 158% decline year-over-year.
- Soleno Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$65.4M, a 130% decline year-over-year.
- Soleno Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$39M, a 62% decline from 2022.
- Soleno Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$24.1M, a 22.1% increase from 2021.
- Soleno Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.9M, a 25.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)